Literature DB >> 3291791

B27 positive diseases versus B27 negative diseases.

A Linssen1, T E Feltkamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3291791      PMCID： PMC1003540          DOI： 10.1136/ard.47.5.431

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  57 in total

1.  Diagnostic criteria for population studies.

Authors:  J H KELLGREN
Journal:  Bull Rheum Dis       Date:  1962-11

Review 2.  Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome.

Authors:  J M Moll; I Haslock; I F Macrae; V Wright
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

3.  HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.

Authors:  K Aho; P Ahvonen; A Lassus; K Sievers; A Tiilikainen
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

4.  HL-A (transplantation) antigens in ankylosing spondylitis and Crohn's disease.

Authors:  A S Russell; J Schlaut; J S Percy; J B Dossetor
Journal:  J Rheumatol       Date:  1974-06       Impact factor: 4.666

5.  HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; D C James
Journal:  Lancet       Date:  1974-05-18       Impact factor: 79.321

6.  Letter: Salmonella arthritis and HL-A27.

Authors:  J Friis; A Svejgaard
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

7.  Acute anterior uveitis and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

8.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

9.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

10.  Genetics of ankylosing spondylitis.

Authors:  A E Emery; J S Lawrence
Journal:  J Med Genet       Date:  1967-12       Impact factor: 6.318
View more
  9 in total

Review 1.  Two forms of reactive arthritis?

Authors:  P Toivanen; A Toivanen
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

Review 2.  HLA and uveitis.

Authors:  T E Feltkamp
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

Review 3.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 4.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

Review 5.  HLA-B27 and spondyloarthropathy: value for early diagnosis?

Authors:  J T Gran; G Husby
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

6.  Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin.

Authors:  T L Reynolds; M A Khan; S van der Linden; R P Cleveland
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

7.  Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study.

Authors:  A Frydén; A Bengtsson; U Foberg; B Svenungsson; B Castor; A Kärnell; R Schvarcz; B Lindblom; E Kihlström
Journal:  BMJ       Date:  1990-12-08

8.  Spondylarthropathy and selective IgA deficiency.

Authors:  S H Sprenkels; A Linssen; T E Feltkamp
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?

Authors:  Miranda van Lunteren; Désirée van der Heijde; Alexandre Sepriano; Inger J Berg; Maxime Dougados; Laure Gossec; Lennart Jacobsson; Roberta Ramonda; Martin Rudwaleit; Joachim Sieper; Robert Landewé; Floris A van Gaalen
Journal:  Rheumatology (Oxford)       Date:  2019-09-01       Impact factor: 7.580
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.